FIELD: medicine.
SUBSTANCE: composition contains cytokine, dextrane, sodium chloride, alpha tocopherol acetate, Trilon, benzalkonium chloride, Polysorbate and phosphate mixture in the following ratio: cytokine 1×10-5-5×10-1 mg/ml; alpha tocopherol acetate 0.05-0.1 mg/ml; hydrolysed dextrane 0.1-0.5 mg/ml; benzalkonium chloride 0.1-0.2 mg/ml; Polysorbate 0.3-1.0 mg/ml; sodium chloride 50-100 mg/ml; Trilon 5-10 mg/ml; a solution of buffer-forming phosphates - the rest. Interferon, interleukin or their receptor antagonist is used as cytokine.
EFFECT: composition exhibits improved fluid storage characteristics and higher rheology.
6 cl, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING RECOMBINANT INTERFERON ALPHA-2b AND INTERFERON-CONTAINING PREPARATION (VARIANTS) | 2005 |
|
RU2294372C1 |
| COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
| CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 |
|
RU2554495C2 |
| CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITION OF A RECOMBINANT MONOCLONAL ANTIBODY TO TNF-α | 2017 |
|
RU2764521C2 |
| INTERFERON-CONTAINING AEROSOL COMPOSITION "NIKOFEN" | 2004 |
|
RU2277904C2 |
| IMMUNOSTIMULATING DRUG AND METHOD FOR PREPARING IT | 2008 |
|
RU2432171C2 |
| COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS AND IMMUNOMODULATORY ACTION | 2009 |
|
RU2404797C1 |
| RECOMBINANT MONOCLONAL ANTIBODY TO TNF-ALPHA AQUEOUS PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2665966C2 |
| HEMOSTIMULANT AND PHARMACEUTICAL COMPOSITION AND METHOD FOR HEMOPOIESIS STIMULATION | 2011 |
|
RU2482869C1 |
